Merck (MRK) Reports a Negative Operating Margin and Pays Out 266% of Earnings. What Explains Both?
Merck & Co., Inc. (NYSE:MRK) closed at $145.45 on October 12.
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 40,000 | $5,812,400 | 3.32% | |
| 2. | Bailard Inc Thomas Bailard | 28,801 | $4,185,176 | +8% | 0.08% |
| 3. | Zevenbergen Capital Investments Nancy Zevenbergen | 1,565 | $227,410 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | $249,999.98 | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | $1,327,500.00 | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | $341.04 | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | $14,343.92 | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | $1,201.20 | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $135.00 | 10,000 | $1,350,000.00 | 36,613 | 2026-08-13 | Filing | |
| $133.46 | 80,315 | $10,718,494.55 | 45,509 | 2026-08-12 | Filing | |
| $132.04 | 600 | $79,222.02 | 110,167 | 2026-08-12 | Filing | |
| $131.61 | 11,099 | $1,460,770.47 | 110,767 | 2026-08-12 | Filing | |
| $132.35 | 5,427 | $718,261.28 | 121,866 | 2026-08-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 644,977 | $96,282,167 | 5.08% | |
| 2. | 532,699 | $77,406,461 | 1.04% | |
| 3. | 458,433 | $66,614,899 | 2.55% | |
| 4. | 369,628 | $53,710,645 | 0.64% | |
| 5. | 337,040 | $48,975,282 | 2.15% |
News See All
3 ETFs With At Least 13% Upside Potential, According to the AI Analyst
TipRanks’ ETF AI Analyst sees at least 13% upside potential in iShares Core S&P Mid-Cap ETF ($IJH), Schwab US Dividend Equity ETF ($SCHD)...
Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why
Moderna shares ($MRNA) climbed by 13% to around $223 on Friday afternoon, pushing the U.S. biotech and pharma company past its one-year high of $21...
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
AI startup BioinvestGPT predicted the failure of Novartis AG’s ($NVS) experimental muscular dystrophy drug months before a disappointing Phase 3 re...
10 Best Bear Market Stocks to Invest In Right Now
U.S. consumer prices rose 3.4% in the year through August 2026, while the measure excluding food and energy increased 2.4%, according to the Bureau of Labor Statistics' September 11 release.
Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories
Obesity drugs, pipeline investment, and manufacturing capacity are reshaping the pharmaceutical industry's growth equation.
Warner Bros. Is Set to Leave Nasdaq 100 and S&P 500 Indexes after $81 Billion Paramount Buyout
Warner Bros. Discovery ($WBD) is set to leave both the Nasdaq 100 and S&P 500 main indexes next week. The entertainment giant is finishing an $81 b...
3 ETFs to Buy with At Least 13% Upside Potential, According to the AI Analyst
TipRanks’ ETF AI Analyst sees at least 13% upside potential in Vanguard Growth ETF ($VUG), SPDR Portfolio S&P 500 Growth ETF ($SPYG), and iShares C...
3 ETF Bets with 11%+ Upside, According to AI Analyst
Exchange-traded funds (ETFs) remain a key way to capture growth opportunities in the market. Investors seeking exposure to industries such as tech,...
Merck & Co (MRK) Has Billions in Revenue to Defend. Can its Pipeline Do the Job?
On September 24, Merck & Co., Inc.
Hedge Fund Resource Center